The Optical Distributors and Manufacturers Association of Australia (ODMA) has revealed it held private negotiations in an attempt to resolve the revocation of an eyewear tariff concession and is currently reviewing all immediate available alternative courses of action. Read more
AbbVie and iSTAR Medical form glaucoma treatment alliance
Biopharmaceutical company AbbVie and Belgium medical technology manufacturer iSTAR Medical have announced a strategic alliance to further develop and commercialise iSTAR Medical’s MINIject, a minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma. Read more
Martin Gregory elected Eyecare Plus chairman
Mr Martin Gregory, a director of Eyecare Plus for the past 11 years, has been unanimously elected by the Eyecare Plus Board to replace chairman Mr Justin Durkin who has retired after nine years in the role. Read more
George & Matilda expands with Albany Creek Optometrists
George & Matilda (G&M) Eyecare has welcomed Albany Creek Optometrists and independent optometrist Mr Philip Brinin to its expanding community of practices. Read more
MiSight myopia control contact lenses now available in higher prescriptions
CooperVision has announced its MiSight 1 day contact lenses are now available in higher prescriptions, making myopia control accessible to more children than was previously possible. Read more
Work-readiness of Aussie optometry graduates under microscope
Optometry graduate employers are being invited to take part in the Australian Government’s Employer Satisfaction Survey (ESS), which ends mid-August. Read more
Stressed health system impacting Australian eye donations
New Australian Government data of organ and tissue donation shows eye donations are up 12% year-on-year, but a leading eye bank director says stress on the health system is contributing to lower rates compared to pre-pandemic levels. Read more
Zeiss and Precise Bio to accelerate bio-fabricated corneal tissue program
Carl Zeiss Meditec has revealed a new partnership with Precise Bio to develop fabricated corneal tissue, leveraging a new 4D bio-fabrication platform that is set to address a major unmet need in ophthalmology. Read more
Latest developments in keratoconus to be explored at KeraClub 2022
Ground-breaking research and the latest developments in keratoconus will be shared next month at KeraClub 2022, a hybrid event for people with the condition, their families, and carers. Read more
Macular Disease Foundation Australia appoints Dr Kathy Chapman as CEO
Macular Disease Foundation Australia (MDFA) has appointed Dr Kathy Chapman as its new CEO, taking over the role from Ms Dee Hopkins, who departed in June after leading the organisation for the past five years. Read more